Immucell (ICCC) Restructuring Costs (2022)
Immucell's (ICCC) quarterly Restructuring Costs came in at $528329.0 in Q2 2022, down 22.89% quarter-over-quarter from $685179.0 in Q1 2022.
Powered by 
Analysis
Immucell (ICCC) Restructuring Costs (2022) Analysis & Trends
Immucell (ICCC) has reported Restructuring Costs for 1 consecutive years, with $528329.0 the latest figure, recorded in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.38 Bn | 40.18 Bn | 779.09 Mn |
| 2 | Zoetis | 30.28 Bn | 28.60 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.59 Bn | 11.06 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn |
| 5 | Immucell | 90.01 Mn | 81.15 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 74.82 Mn | 67.72 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |